9-Monodemethyl Minocycline (CAS 4769-39-5)

9-Monodemethyl Minocycline, registered under the CAS number 4769-39-5, is a chemically modified derivative of minocycline, a compound originally belonging to the tetracycline class of antibiotics. This derivative is characterized by the demethylation at the 9 position of the minocycline molecule. The primary mechanism by which 9-Monodemethyl Minocycline exerts its action involves the inhibition of protein synthesis in bacteria. It achieves this by specifically binding to the 30S ribosomal subunit, thereby blocking the attachment of aminoacyl-tRNA to the mRNA-ribosome complex at the ribosomal acceptor (A) site. This action inhibits the addition of new amino acids to the nascent peptide chain, effectively stalling protein synthesis. In research environments, 9-Monodemethyl Minocycline is utilized to investigate the structural and functional impacts of the demethylation on the activity and binding affinity of the parent compound. These studies help delineate how minor modifications influence the compound′s interaction with bacterial ribosomes and its overall antibacterial efficacy. Additionally, research involving this derivative contributes to the understanding of resistance mechanisms that bacteria develop against tetracyclines, guiding efforts in the development of new molecules that might circumvent or overcome such resistance.